162 related articles for article (PubMed ID: 11755365)
1. Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.
Andrés JI; Alcázar J; Alonso JM; Díaz A; Fernández J; Gil P; Iturrino L; Matesanz E; Meert TF; Megens A; Sipido VK
Bioorg Med Chem Lett; 2002 Jan; 12(2):249-53. PubMed ID: 11755365
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.
Andrés JI; Alcázar J; Alonso JM; Díaz A; Fernández J; Gil P; Iturrino L; Matesanz E; Meert TF; Megens A; Sipido VK
Bioorg Med Chem Lett; 2002 Jan; 12(2):243-8. PubMed ID: 11755364
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.
Cid J; Alonso JM; Andrés JI; Fernández J; Gil P; Iturrino L; Matesanz E; Meert TF; Megens A; Sipido VK; Trabanco AA
Bioorg Med Chem Lett; 2004 Jun; 14(11):2765-71. PubMed ID: 15125929
[TBL] [Abstract][Full Text] [Related]
4. Novel 2-N,N-dimethylaminomethyl-2,3,3a,12b-tetrahydrodibenzo[b,f]furo[2,3-d]oxepin derivatives displaying combined norepinephrine reuptake inhibition and 5-HT2A/2C receptor antagonism.
Bartolomé JM; Alcudia A; Andrés JI; Cid JM; García M; Megens A; Toledo MA; Trabanco AA
Bioorg Med Chem Lett; 2005 Jun; 15(11):2898-901. PubMed ID: 15911276
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
[TBL] [Abstract][Full Text] [Related]
6. 2-(Dimethylaminomethyl)-tetrahydroisoxazolopyridobenzazepine derivatives. Synthesis of a new 5-HT(2C) antagonist with potential anxiolytic properties.
Andrés JI; Alonso JM; Fernández J; Iturrino L; Martínez P; Meert TF; Sipido VK
Bioorg Med Chem Lett; 2002 Dec; 12(24):3573-7. PubMed ID: 12443779
[TBL] [Abstract][Full Text] [Related]
7. 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
Shireman BT; Dvorak CA; Rudolph DA; Bonaventure P; Nepomuceno D; Dvorak L; Miller KL; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2008 Mar; 18(6):2103-8. PubMed ID: 18282705
[TBL] [Abstract][Full Text] [Related]
8. New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.
Brea J; Rodrigo J; Carrieri A; Sanz F; Cadavid MI; Enguix MJ; Villazón M; Mengod G; Caro Y; Masaguer CF; Raviña E; Centeno NB; Carotti A; Loza MI
J Med Chem; 2002 Jan; 45(1):54-71. PubMed ID: 11754579
[TBL] [Abstract][Full Text] [Related]
9. Modification of the structure of 4, 6-disubstituted 2-(4-alkyl-1-piperazinyl)pyridines: synthesis and their 5-HT2A receptor activity.
Paluchowska MH; Bojarski AJ; Bugno R; Charakchieva-Minol S; Wesołowska A
Arch Pharm (Weinheim); 2003 Apr; 336(2):104-10. PubMed ID: 12761763
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 5-HT(2A) and 5-HT(2C) receptor binding affinities of novel pyrimidine derivatives.
Bózsing D; Simonek I; Simig G; Jakóczi I; Gacsályi I; Lévay G; Tihanyi K; Schmidt E
Bioorg Med Chem Lett; 2002 Nov; 12(21):3097-9. PubMed ID: 12372510
[TBL] [Abstract][Full Text] [Related]
11. Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands.
Caliendo G; Fiorino F; Perissutti E; Severino B; Gessi S; Cattabriga E; Borea PA; Santagada V
Eur J Med Chem; 2001; 36(11-12):873-86. PubMed ID: 11755230
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists.
Shimada I; Maeno K; Kondoh Y; Kaku H; Sugasawa K; Kimura Y; Hatanaka K; Naitou Y; Wanibuchi F; Sakamoto S; Tsukamoto S
Bioorg Med Chem; 2008 Mar; 16(6):3309-20. PubMed ID: 18083579
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and pharmacological characterization of N- and O-substituted 5,6,7,8-tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol analogues: novel 5-HT(2A)/5-HT(2C) receptor agonists with pro-cognitive properties.
Jensen AA; Plath N; Pedersen MH; Isberg V; Krall J; Wellendorph P; Stensbøl TB; Gloriam DE; Krogsgaard-Larsen P; Frølund B
J Med Chem; 2013 Feb; 56(3):1211-27. PubMed ID: 23301527
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.
Chambers JJ; Parrish JC; Jensen NH; Kurrasch-Orbaugh DM; Marona-Lewicka D; Nichols DE
J Med Chem; 2003 Jul; 46(16):3526-35. PubMed ID: 12877591
[TBL] [Abstract][Full Text] [Related]
15. Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors.
Acuña-Castillo C; Villalobos C; Moya PR; Sáez P; Cassels BK; Huidobro-Toro JP
Br J Pharmacol; 2002 Jun; 136(4):510-9. PubMed ID: 12055129
[TBL] [Abstract][Full Text] [Related]
16. Role of 5-HT(2) receptors in the tryptamine-induced 5-HT syndrome in rats.
Van Oekelen D; Megens A; Meert T; Luyten WH; Leysen JE
Behav Pharmacol; 2002 Jul; 13(4):313-8. PubMed ID: 12218512
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and 5-HT(1A), 5-HT(2A) receptor activity of new beta-tetralonohydantoins.
Byrtus H; Pawłowski M; Czopek A; Bojarski AJ; Duszyńska B; Nowak G; Kłodzińska A; Tatarczyńska E; Wesołowska A; Chojnacka-Wójcik E
Eur J Med Chem; 2005 Aug; 40(8):820-9. PubMed ID: 16122584
[TBL] [Abstract][Full Text] [Related]
18. Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.
Heffernan GD; Coghlan RD; Manas ES; McDevitt RE; Li Y; Mahaney PE; Robichaud AJ; Huselton C; Alfinito P; Bray JA; Cosmi SA; Johnston GH; Kenney T; Koury E; Winneker RC; Deecher DC; Trybulski EJ
Bioorg Med Chem; 2009 Nov; 17(22):7802-15. PubMed ID: 19836247
[TBL] [Abstract][Full Text] [Related]
19. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
[TBL] [Abstract][Full Text] [Related]
20. 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists.
Zhao SH; Berger J; Clark RD; Sethofer SG; Krauss NE; Brothers JM; Martin RS; Misner DL; Schwab D; Alexandrova L
Bioorg Med Chem Lett; 2007 Jun; 17(12):3504-7. PubMed ID: 17485206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
